Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease. [electronic resource] by
- Howarth, J L
- Kelly, S
- Keasey, M P
- Glover, Cpj
- Lee, Y-B
- Mitrophanous, K
- Chapple, J P
- Gallo, J M
- Cheetham, M E
- Uney, J B
Publication details: Molecular therapy : the journal of the American Society of Gene Therapy Jun 2007
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 15
Availability: No items available.
|
|
|
58.
|
Cytosolic and ER J-domains of mammalian and parasitic origin can functionally interact with DnaK. [electronic resource] by
- Nicoll, W S
- Botha, M
- McNamara, C
- Schlange, M
- Pesce, E-R
- Boshoff, A
- Ludewig, M H
- Zimmermann, R
- Cheetham, M E
- Chapple, J P
- Blatch, G L
Producer: 20070611
In:
The international journal of biochemistry & cell biology vol. 39
Availability: No items available.
|
|
|
59.
|
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. [electronic resource] by
- Howarth, J L
- Kelly, S
- Keasey, M P
- Glover, C P J
- Lee, Y-B
- Mitrophanous, K
- Chapple, J P
- Gallo, J M
- Cheetham, M E
- Uney, J B
Producer: 20070925
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 15
Availability: No items available.
|
|
|
60.
|
An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene. [electronic resource] by
- Dandekar, S S
- Ebenezer, N D
- Grayson, C
- Chapple, J P
- Egan, C A
- Holder, G E
- Jenkins, S A
- Fitzke, F W
- Cheetham, M E
- Webster, A R
- Hardcastle, A J
Producer: 20040511
In:
The British journal of ophthalmology vol. 88
Availability: No items available.
|